Header Logo

Connection

Christopher Codispoti to Anti-Asthmatic Agents

This is a "connection" page, showing publications Christopher Codispoti has written about Anti-Asthmatic Agents.
Connection Strength

0.882
  1. Mepolizumab utility in successful aspirin desensitization in aspirin-exacerbated respiratory disease in a refractory case. Ann Allergy Asthma Immunol. 2019 09; 123(3):311-312.
    View in: PubMed
    Score: 0.696
  2. Clinical course of asthma in 4 cases of coronavirus disease 2019 infection. Ann Allergy Asthma Immunol. 2020 08; 125(2):208-210.
    View in: PubMed
    Score: 0.185
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.